{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-029840","form_type":"8-K","ticker":"PLSH","cik":"0001552189","company_name":"PANACEA LIFE SCIENCES HOLDINGS, INC.","filed_at":"2021-11-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.998511+00:00","generated_at":"2026-06-28T05:29:12.937678+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Panacea Life Sciences secures $1M via convertible note and warrant sale to Lincoln Park Capital","bullets":["Sold $1.1M senior convertible note (net $1M) and warrants for 785,715 shares at $1.40 to Lincoln Park Capital Fund.","Note due Nov 18, 2022; 12% interest if SEC filings missed, 18% on default; conversion at $1.40.","Warrants exercisable from May 18, 2022 for 5 years at $1.40; 4.99% beneficial ownership cap.","Investor may buy an additional $1.1M note and warrants on same terms within 91 business days."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-029840","json":"https://secwatch.observer/filing/0001493152-21-029840.json","markdown":"https://secwatch.observer/filing/0001493152-21-029840.md","text":"https://secwatch.observer/filing/0001493152-21-029840.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1552189/000149315221029840/0001493152-21-029840-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1552189/000149315221029840/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T05:29:12.937678+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}